Senior Counsel, Small Molecule-Innovation Law at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Registered to practice before the USPTO
A J.D. degree and admission to at least one state bar is preferred
10 or more years of patent law experience in the pharmaceutical/biotechnology industry
Bachelor’s degree or equivalent in chemistry, biochemistry, or pharmaceutical sciences. An advanced degree and/or scientific research experience is preferred
Excellent analytical, written, and verbal communication skills
Service-oriented focus with the ability to work as part of cross-functional teams and drive results
Highest integrity, excellent judgment, and the ability to proactively recognize and effectively assess business risk and communicate legal issues to patent, legal, and key stakeholders

Responsibilities

Prepare and prosecute patent applications, including drafting, filing, and managing responses to office actions on a global level
Provide comprehensive program counseling to various functional areas, ensuring alignment with BMS’s strategic objectives
Develop and implement advanced IP strategies to protect BMS’s innovations and support business goals
Lead cross-functional collaboration efforts working closely with R&D, regulatory, commercial, and other departments to achieve project milestones
Conduct freedom-to-operate analyses and provide strategic counsel on patentability and infringement issues
Manage patent portfolios, including conducting patent landscape analyses and developing patent strategies to protect BMS's innovations
Provide due diligence support for business development activities, including evaluating IP portfolios of potential partners and acquisition targets
Draft and negotiate license and research collaboration agreements
Manage relationships with outside counsel to ensure high-quality and cost-effective legal services
Regularly engage with business and technical teams to provide IP-related guidance and support
Stay updated on changes in patent laws and regulations and ensure compliance with all relevant legal requirements

Skills

Patent Drafting

Patent Prosecution

Office Actions

Freedom to Operate

Due Diligence

IP Counseling

Global Patent Filing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free